
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The association between plasma and MRI biomarkers in dementia with lewy bodies - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5329ED8AF198730529ED0085EFB9F6.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="alzreth">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374387/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Alzheimer&#x27;s Research &amp; Therapy">
<meta name="citation_title" content="The association between plasma and MRI biomarkers in dementia with lewy bodies">
<meta name="citation_author" content="Carmen Peña-Bautista">
<meta name="citation_author_institution" content="Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden">
<meta name="citation_author_institution" content="Alzheimer’s Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain">
<meta name="citation_author" content="Katharina Bolsewig">
<meta name="citation_author_institution" content="Neurochemistry Laboratory, Laboratory Medicine Department, Amsterdam Neuroscience, VU University Medical Centers, Amsterdam UMC, Amsterdam, The Netherlands">
<meta name="citation_author" content="Maria C Gonzalez">
<meta name="citation_author_institution" content="Department of Quality and Health Technology, University of Stavanger, Stavanger, Norway">
<meta name="citation_author_institution" content="The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway">
<meta name="citation_author_institution" content="Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway">
<meta name="citation_author" content="Nicholas J Ashton">
<meta name="citation_author_institution" content="Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway">
<meta name="citation_author_institution" content="Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden">
<meta name="citation_author_institution" content="Department of Old Age Psychiatry, King’s College London, London, UK">
<meta name="citation_author" content="Dag Aarsland">
<meta name="citation_author_institution" content="Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden">
<meta name="citation_author_institution" content="Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway">
<meta name="citation_author_institution" content="Department of Old Age Psychiatry, King’s College London, London, UK">
<meta name="citation_author" content="Henrik Zetterberg">
<meta name="citation_author_institution" content="Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden">
<meta name="citation_author_institution" content="Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden">
<meta name="citation_author_institution" content="Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK">
<meta name="citation_author_institution" content="UK Dementia Research Institute at UCL, London, UK">
<meta name="citation_author_institution" content="Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China">
<meta name="citation_author_institution" content="Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, USA">
<meta name="citation_author" content="Eric Westman">
<meta name="citation_author_institution" content="Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden">
<meta name="citation_author" content="Olivier Bousiges">
<meta name="citation_author_institution" content="GeRMINED Division, Service of Gerontology Mobile-Neuro-Psy-Research, University Hospitals of Strasbourg, CM2R (Research and Resources Memory Centre), Strasbourg, France">
<meta name="citation_author_institution" content="University of Strasbourg and CNRS, ICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS Team, Strasbourg, France">
<meta name="citation_author" content="Frederic Blanc">
<meta name="citation_author_institution" content="GeRMINED Division, Service of Gerontology Mobile-Neuro-Psy-Research, University Hospitals of Strasbourg, CM2R (Research and Resources Memory Centre), Strasbourg, France">
<meta name="citation_author_institution" content="University of Strasbourg and CNRS, ICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS Team, Strasbourg, France">
<meta name="citation_author" content="Charlotte E Teunissen">
<meta name="citation_author_institution" content="Neurochemistry Laboratory, Laboratory Medicine Department, Amsterdam Neuroscience, VU University Medical Centers, Amsterdam UMC, Amsterdam, The Netherlands">
<meta name="citation_author" content="Afina W Lemstra">
<meta name="citation_author_institution" content="Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands">
<meta name="citation_author" content="Consuelo Cháfer-Pericás">
<meta name="citation_author_institution" content="Alzheimer’s Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain">
<meta name="citation_author" content="Miguel Baquero">
<meta name="citation_author_institution" content="Alzheimer’s Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain">
<meta name="citation_author_institution" content="Division of Neurology, Hospital Universitari I Politècnic La Fe, Valencia, Spain">
<meta name="citation_author" content="Daniel Ferreira">
<meta name="citation_author_institution" content="Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden">
<meta name="citation_author_institution" content="Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas, Spain">
<meta name="citation_publication_date" content="2025 Aug 22">
<meta name="citation_volume" content="17">
<meta name="citation_firstpage" content="197">
<meta name="citation_doi" content="10.1186/s13195-025-01848-x">
<meta name="citation_pmid" content="40847319">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374387/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374387/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374387/pdf/13195_2025_Article_1848.pdf">
<meta name="description" content="The diagnosis of Dementia with Lewy Bodies (DLB) is primarily based on clinical features. The main driver of DLB is alpha-synuclein-related pathology, but cerebrovascular disease (CVD) and Alzheimer’s Disease (AD) co-pathologies are often found in ...">
<meta name="og:title" content="The association between plasma and MRI biomarkers in dementia with lewy bodies">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The diagnosis of Dementia with Lewy Bodies (DLB) is primarily based on clinical features. The main driver of DLB is alpha-synuclein-related pathology, but cerebrovascular disease (CVD) and Alzheimer’s Disease (AD) co-pathologies are often found in ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374387/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374387">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s13195-025-01848-x"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/13195_2025_Article_1848.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374387%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374387/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374387/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374387/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-alzreth.png" alt="Alzheimer's Research &amp; Therapy logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Alzheimer's Research &amp; Therapy" title="Link to Alzheimer's Research &amp; Therapy" shape="default" href="https://alzres.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Alzheimers Res Ther</button></div>. 2025 Aug 22;17:197. doi: <a href="https://doi.org/10.1186/s13195-025-01848-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s13195-025-01848-x</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Alzheimers%20Res%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alzheimers%20Res%20Ther%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Alzheimers%20Res%20Ther%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Alzheimers%20Res%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The association between plasma and MRI biomarkers in dementia with lewy bodies</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pe%C3%B1a-Bautista%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Carmen Peña-Bautista</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Carmen Peña-Bautista</span></h3>
<div class="p">
<sup>1</sup>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden </div>
<div class="p">
<sup>2</sup>Alzheimer’s Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pe%C3%B1a-Bautista%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carmen Peña-Bautista</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bolsewig%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Katharina Bolsewig</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Katharina Bolsewig</span></h3>
<div class="p">
<sup>3</sup>Neurochemistry Laboratory, Laboratory Medicine Department, Amsterdam Neuroscience, VU University Medical Centers, Amsterdam UMC, Amsterdam, The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bolsewig%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Katharina Bolsewig</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gonzalez%20MC%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Maria C Gonzalez</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Maria C Gonzalez</span></h3>
<div class="p">
<sup>4</sup>Department of Quality and Health Technology, University of Stavanger, Stavanger, Norway </div>
<div class="p">
<sup>5</sup>The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway </div>
<div class="p">
<sup>6</sup>Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gonzalez%20MC%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria C Gonzalez</span></a>
</div>
</div>
<sup>4,</sup><sup>5,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ashton%20NJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Nicholas J Ashton</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Nicholas J Ashton</span></h3>
<div class="p">
<sup>6</sup>Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway </div>
<div class="p">
<sup>7</sup>Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden </div>
<div class="p">
<sup>8</sup>Department of Old Age Psychiatry, King’s College London, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ashton%20NJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Nicholas J Ashton</span></a>
</div>
</div>
<sup>6,</sup><sup>7,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aarsland%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Dag Aarsland</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Dag Aarsland</span></h3>
<div class="p">
<sup>1</sup>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden </div>
<div class="p">
<sup>6</sup>Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway </div>
<div class="p">
<sup>8</sup>Department of Old Age Psychiatry, King’s College London, London, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aarsland%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dag Aarsland</span></a>
</div>
</div>
<sup>1,</sup><sup>6,</sup><sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zetterberg%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Henrik Zetterberg</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Henrik Zetterberg</span></h3>
<div class="p">
<sup>7</sup>Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden </div>
<div class="p">
<sup>9</sup>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden </div>
<div class="p">
<sup>10</sup>Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK </div>
<div class="p">
<sup>11</sup>UK Dementia Research Institute at UCL, London, UK </div>
<div class="p">
<sup>12</sup>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China </div>
<div class="p">
<sup>13</sup>Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zetterberg%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Henrik Zetterberg</span></a>
</div>
</div>
<sup>7,</sup><sup>9,</sup><sup>10,</sup><sup>11,</sup><sup>12,</sup><sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Westman%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Eric Westman</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Eric Westman</span></h3>
<div class="p">
<sup>1</sup>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Westman%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Eric Westman</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bousiges%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Olivier Bousiges</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Olivier Bousiges</span></h3>
<div class="p">
<sup>14</sup>GeRMINED Division, Service of Gerontology Mobile-Neuro-Psy-Research, University Hospitals of Strasbourg, CM2R (Research and Resources Memory Centre), Strasbourg, France </div>
<div class="p">
<sup>15</sup>University of Strasbourg and CNRS, ICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS Team, Strasbourg, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bousiges%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Olivier Bousiges</span></a>
</div>
</div>
<sup>14,</sup><sup>15</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blanc%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Frederic Blanc</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Frederic Blanc</span></h3>
<div class="p">
<sup>14</sup>GeRMINED Division, Service of Gerontology Mobile-Neuro-Psy-Research, University Hospitals of Strasbourg, CM2R (Research and Resources Memory Centre), Strasbourg, France </div>
<div class="p">
<sup>15</sup>University of Strasbourg and CNRS, ICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS Team, Strasbourg, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Blanc%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Frederic Blanc</span></a>
</div>
</div>
<sup>14,</sup><sup>15</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Teunissen%20CE%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Charlotte E Teunissen</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Charlotte E Teunissen</span></h3>
<div class="p">
<sup>3</sup>Neurochemistry Laboratory, Laboratory Medicine Department, Amsterdam Neuroscience, VU University Medical Centers, Amsterdam UMC, Amsterdam, The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Teunissen%20CE%22%5BAuthor%5D" class="usa-link"><span class="name western">Charlotte E Teunissen</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lemstra%20AW%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Afina W Lemstra</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Afina W Lemstra</span></h3>
<div class="p">
<sup>16</sup>Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lemstra%20AW%22%5BAuthor%5D" class="usa-link"><span class="name western">Afina W Lemstra</span></a>
</div>
</div>
<sup>16</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ch%C3%A1fer-Peric%C3%A1s%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Consuelo Cháfer-Pericás</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Consuelo Cháfer-Pericás</span></h3>
<div class="p">
<sup>2</sup>Alzheimer’s Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ch%C3%A1fer-Peric%C3%A1s%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Consuelo Cháfer-Pericás</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baquero%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Miguel Baquero</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Miguel Baquero</span></h3>
<div class="p">
<sup>2</sup>Alzheimer’s Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain </div>
<div class="p">
<sup>17</sup>Division of Neurology, Hospital Universitari I Politècnic La Fe, Valencia, Spain </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baquero%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Miguel Baquero</span></a>
</div>
</div>
<sup>2,</sup><sup>17</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferreira%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Daniel Ferreira</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Daniel Ferreira</span></h3>
<div class="p">
<sup>1</sup>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden </div>
<div class="p">
<sup>18</sup>Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas, Spain </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ferreira%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Daniel Ferreira</span></a>
</div>
</div>
<sup>1,</sup><sup>18,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, NEO floor 7th, Stockholm, Huddinge, 141 83 SE Sweden </div>
<div id="Aff2">
<sup>2</sup>Alzheimer’s Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain </div>
<div id="Aff3">
<sup>3</sup>Neurochemistry Laboratory, Laboratory Medicine Department, Amsterdam Neuroscience, VU University Medical Centers, Amsterdam UMC, Amsterdam, The Netherlands </div>
<div id="Aff4">
<sup>4</sup>Department of Quality and Health Technology, University of Stavanger, Stavanger, Norway </div>
<div id="Aff5">
<sup>5</sup>The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway </div>
<div id="Aff6">
<sup>6</sup>Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway </div>
<div id="Aff7">
<sup>7</sup>Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden </div>
<div id="Aff8">
<sup>8</sup>Department of Old Age Psychiatry, King’s College London, London, UK </div>
<div id="Aff9">
<sup>9</sup>Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden </div>
<div id="Aff10">
<sup>10</sup>Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK </div>
<div id="Aff11">
<sup>11</sup>UK Dementia Research Institute at UCL, London, UK </div>
<div id="Aff12">
<sup>12</sup>Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China </div>
<div id="Aff13">
<sup>13</sup>Wisconsin Alzheimer’s Disease Research Center, University of Wisconsin School of Medicine and Public Health, Madison, USA </div>
<div id="Aff14">
<sup>14</sup>GeRMINED Division, Service of Gerontology Mobile-Neuro-Psy-Research, University Hospitals of Strasbourg, CM2R (Research and Resources Memory Centre), Strasbourg, France </div>
<div id="Aff15">
<sup>15</sup>University of Strasbourg and CNRS, ICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS Team, Strasbourg, France </div>
<div id="Aff16">
<sup>16</sup>Alzheimer Center Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands </div>
<div id="Aff17">
<sup>17</sup>Division of Neurology, Hospital Universitari I Politècnic La Fe, Valencia, Spain </div>
<div id="Aff18">
<sup>18</sup>Facultad de Ciencias de la Salud, Universidad Fernando Pessoa Canarias, Las Palmas, Spain </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 May 14; Accepted 2025 Aug 14; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374387  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40847319/" class="usa-link">40847319</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">The diagnosis of Dementia with Lewy Bodies (DLB) is primarily based on clinical features. The main driver of DLB is alpha-synuclein-related pathology, but cerebrovascular disease (CVD) and Alzheimer’s Disease (AD) co-pathologies are often found in patients with DLB. Fluid biomarkers and magnetic resonance imaging (MRI) can provide mechanistic and diagnostic information beyond clinical features. Therefore, the aim of this study was to investigate the association of plasma biomarkers (GFAP, NfL, Aβ42/40, pTau231, pTau181) with MRI markers of neurodegeneration and CVD in DLB and in patients with AD as a control group. We also evaluated the ability of biomarkers and clinical features to discriminate between DLB and AD.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">We included 134 patients from the European DLB consortium (DLB (<em>n</em> = 92) and AD (<em>n</em> = 43)) with plasma biomarkers determined with Simoa and MRI assessed with radiological scales for medial temporal lobe atrophy (MTA), global cortical atrophy scale – frontal subscale (GCA-F), posterior atrophy (PA), and cerebrovascular disease (Fazekas scale). Associations between plasma and MRI biomarkers were assessed with the Mann-Whitney <em>U</em> test, and group differences and the discrimination between DLB and AD were assessed with ANCOVA, Random Forest, and ROC analyses.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">In DLB, plasma concentrations of GFAP and NfL were associated with MTA, GCA-F, and Fazekas scale; and the Aβ42/40 ratio was associated with PA and Fazekas. Most of these associations were not statistically significant in AD. Individually, plasma and MRI biomarkers had a limited ability to discriminate DLB from AD. Plasma biomarkers helped increase the low specificity of core clinical features from 68% up to 79%, keeping the high sensitivity of 90%.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">Plasma biomarkers of AD co-pathology, glial processes and unspecific neurodegeneration are associated with MRI biomarkers of atrophy and cerebrovascular disease in DLB patients. Plasma biomarkers increase the ability of core clinical features to discriminate between DLB and AD.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s13195-025-01848-x.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> DLB, MRI, Blood biomarkers</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par5">Dementia with Lewy Bodies (DLB) is a neurodegenerative dementia primarily caused by intracellular deposits of the misfolded protein alpha-synuclein [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. Other common causes of dementia are Alzheimer’s disease (AD) and cerebrovascular disease (CVD) [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Importantly, patients with DLB may also have AD and CVD co-pathology in their brains, which complicates the diagnosis of DLB [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>].</p>
<p id="Par6">The diagnosis of DLB mostly relies on core clinical features (cognitive fluctuations, visual hallucinations, parkinsonism, and rapid eye movement sleep behaviour disorder (RBD)) and indicative biomarkers (e.g. <sup>123</sup>Iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and Dopamine transporter Scan (DaTSCAN) [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. However, structural imaging such as magnetic resonance imaging (MRI) and computed tomography (CT) is also commonly used in the differential diagnosis between DLB and AD [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>], and is cheaper and more widely available than MIBG and DaTSCAN. A differential distribution of MRI- or CT-based atrophy patterns has been described in AD and DLB [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. These patterns include typical AD, limbic-predominant, hippocampal-sparing, and the minimal atrophy pattern. It has been suggested that part of the clinical heterogeneity in neurodegenerative dementias may depend on these atrophy patterns and the presence of co-pathologies [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>].</p>
<p id="Par7">In biofluids, AD co-pathology can be assessed in-vivo with cerebrospinal fluid (CSF) and plasma biomarkers. Previous studies reported associations of CSF biomarkers of AD (amyloid β (Aβ) and phosphorylated tau (pTau) levels) with brain atrophy, clinical symptoms, and cognitive decline in DLB [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. Furthermore, abnormal CSF concentrations of AD biomarkers have been associated with higher brain alpha-synuclein pathology [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. In recent years, the emergence of plasma biomarkers has revolutionized the diagnostic opportunities in AD. Several studies have assessed the association between plasma biomarkers and neurodegeneration assessed with MRI in AD [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Specifically, a lower plasma Aβ42/40 ratio was significantly associated with greater medial temporal atrophy (MTA) assessed with a visual rating scale on MRI in patients with AD [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Other studies have also demonstrated a significant association between higher levels of pTau181 and brain atrophy (greater cortical thinning and grey matter loss) in patients with AD [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Apart from core plasma AD biomarkers, glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) are proteins found in the astroglia and neuronal axons respectively and, therefore, are considered biomarkers of glial activation or axonal damage [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Higher plasma levels of GFAP and NfL have been associated with more MTA in Aβ-positive patients with subjective cognitive impairment, mild cognitive impairment and dementia, as well as with CVD in incident dementia [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>, <a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. A recent study showed that plasma concentrations of GFAP, NfL, Aβ42/40, and pTau181 predicted positivity in amyloid positron emission tomography (PET) in DLB patients [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. In addition, higher plasma concentrations of GFAP, NfL and pTau181 and 231 have been associated with greater cognitive decline, and higher NfL with a higher frequency of parkinsonism in DLB [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Elucidating the association of plasma biomarkers with MRI measures of neurodegeneration and CVD in DLB, and determining the ability of plasma and MRI biomarkers to discriminate DLB from AD is still needed to inform the mechanisms driving the neurodegenerative process in DLB and understand how to translate that knowledge to the clinical routine for the discrimination between DLB and AD.</p>
<p id="Par8">The aims of this study were to investigate the association of plasma biomarkers of pathological mechanisms involved in neurodegeneration (amyloid, beta, Tau, inflammation and glia activation) with biomarkers of brain atrophy and vascular pathology in DLB. We also investigated the ability of plasma and MRI biomarkers to discriminate DLB from AD on their own and in combination with core clinical features. We chose to use visual rating scales that, although less sensitive than automated volumetric MRI approaches, are more robust to variation in image acquisition parameters and scanner characteristics in multi-center studies. Specifically, we selected a combination of validated rating scales that together offer a global assessment of neurodegeneration and cerebrovascular co-pathology: the MTA scale for neurodegeneration in medial temporal lobes [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>], the global cortical atrophy scale – frontal subscale (GCA-F) for neurodegeneration in frontal lobe [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>], and the posterior atrophy (PA) scale for neurodegeneration in parietal and occipital lobes [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>], as well as the Fazekas scale for white matter signal abnormalities [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>].</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Participants and sample collection</h3>
<p id="Par9">We searched the E-DLB database for all DLB and AD patients with plasma biomarkers and MRI data available [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. A total of 134 patients from 2 E-DLB centres were available, of which 92 had a clinical diagnosis of probable DLB and 43 had a clinical diagnosis of probable AD [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Diagnoses were established by licensed neurologists based on detailed medical history and clinical examinations, including physical, neurologic, and psychiatric examinations [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. DLB core clinical features of visual hallucinations, parkinsonism, and cognitive fluctuations were assessed following the International Consensus criteria, and the Mini-Mental State Examination (MMSE) was recorded as a measure of global cognitive impairment [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>]. </p></section><section id="Sec4"><h3 class="pmc_sec_title">Plasma biomarkers</h3>
<p id="Par10">Plasma concentrations of GFAP, NfL, Aβ42 and Aβ40 were determined using the commercially available Neurology 4-Plex E kit on the Simoa HD-X Analyzer (Quanterix, USA). These biomarkers were analyzed centrally at the Neurochemistry Laboratory of Amsterdam University Medical Centers (Netherlands), as previously described in Bolsewig et al. [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. Additionally, plasma concentrations of pTau231 and pTau181 were determined using a clinically validated in-house single molecule array (Simoa) centrally at the Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal (Sweden), as previously described in Gonzalez et al. [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].</p>
<p id="Par11">Plasma biomarkers Aβ40, Aβ42, GFAP and NfL were measured across three analytical runs in singlicate. Internal quality control samples were included in each run. Repeatability and intermediate precision were determined using three QC samples and showed coefficients of variation below 15% for all biomarkers, as previously described by Bolsewig et al. and González et al. [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Specifically, repeatability CVs ranged from 2.7 to 8.2%, and intermediate precision CVs from 3.3 to 9.7%, depending on the analyte. For plasma biomarkers p-tau181 and p-tau231, all measurements were performed using a single batch of reagents, and analysts were blinded to clinical information. The analytical variation was evaluated by internal quality control samples across the study. These procedures reduced the risk of inter-batch variability and ensured high analytical consistency.</p></section><section id="Sec5"><h3 class="pmc_sec_title">MRI biomarkers</h3>
<p id="Par12">Brain MRI scans were obtained using different scanners and acquisition protocols. To accommodate variability across scanners and protocols, we performed a centralized assessment of scans at Karolinska Institutet (Sweden) using visual rating scales as described previously (Ferreira et al., 2017). Visual ratings were performed on T1-weigthed images using three well-stablished scales: MTA scale [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>], GCA-F subscale [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>], and PA scale [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Additionally, we investigated white matter signal abnormalities as a well-stablished marker of CVD, using the Fazekas scale on FLAIR images [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. MTA scores range from 0 (no atrophy) to 4 (severe atrophy) and were dichotomized as abnormal using age-adjusted cut off values. Specifically, for age ranges 45–64, 65–74, 75–84, and 85–94 years, the corresponding cut off values were MTA scores ≥ 1.5, ≥ 1.5, ≥ 2, ≥2.5, respectively [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. These age-specific cut off values were based on normative data from 345 cognitively healthy individuals and are widely used to establish abnormality in memory clinic populations [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. GCA-F and PA scores range from 0 (no atrophy) to 3 (severe atrophy). GCA-F and PA were dichotomized as normal (0 score) and abnormal (scores ≥ 1), based on prior evidence that age adjustments do not improve their diagnostic performance [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. This approach, supported by previous studies using the same E-DLB dataset [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>], allows for the reliable classification of visual ratings into normal/abnormal without dedicating a specific control group within the study. Fazekas scores range from 0 (no changes) to 3 (highest degree of white matter changes), and there were dichotomized as normal when scores were &lt; 2 and abnormal when ≥ 2, as in previous studies [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. The four atrophy patterns described in previous studies (typical AD, limbic-predominant, hippocampal-sparing, and minimal-atrophy) were defined as a combination of the scores from MTA, GCA-F, and PA [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Typical AD was defined as abnormal MTA, abnormal PA and/or abnormal GCA-F. Limbic-predominant was defined as abnormal MTA, normal PA and GCA-F. Hippocampal-sparing was defined as abnormal PA, and/or abnormal GCA-F, and normal MTA. Minimal-atrophy was defined as normal MTA, PA, and GCA-F.</p>
<p id="Par13">One single expert neuroradiologist rated all the images, blinded to any demographic or clinical information. The neuroradiologist has an excellent intra-rater reliability, with a weighted κ of 0.94 and 0.89 for MTA in left and right hemispheres respectively, 0.83 for GCA-F and 0.88 for PA in 120 random cases [<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>].</p></section><section id="Sec6"><h3 class="pmc_sec_title">Statistical analyses</h3>
<p id="Par14">Group differences for demographic and clinical variables were analysed with the Man-Whitney <em>U</em> test for quantitative variables and the Chi-Square test for categorical variables (sex and years of education).</p>
<p id="Par15">The association between plasma biomarkers and MRI was assessed with the Mann-Whitney <em>U</em> test with dichotomized MRI ratings as the independent variable (normal vs. abnormal) and the continuous measures of plasma biomarkers as the dependent variables, separately for DLB and AD groups.</p>
<p id="Par16">For the study of plasma biomarkers across atrophy subtypes, we used the Kruskal-Wallis test with the Bonferroni correction for post hoc paired-wise comparisons. Effect sizes were estimated from the non-parametric Mann-Whitney <em>U</em> value, considering 0.2 as a small effect, 0.5 as medium, and 0.8 as large [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>].</p>
<p id="Par17">Differences between DLB and AD groups for dichotomized MRI visual ratings (MTA, GCA-F, PA, Fazekas) and continuous plasma biomarkers (GFAP, NfL, Aβ42/40, pTau231, pTau181) were evaluated in two steps. First, group differences were tested with Mann-Whitney <em>U</em> (plasma biomarkers) and Chi-Square (MRI biomarkers) tests. Second, these analyses were followed by ANCOVA correcting for age and MMSE.</p>
<p id="Par18">We also performed ROC analyses to evaluate the ability of plasma and MRI biomarkers to discriminate DLB from AD. These analyses were first performed separately for each individual plasma and MRI biomarker without any correction and next, corrected for age and MMSE with the unstandardized residuals obtained from the ANCOVAs described above. We finally analysed the ability of plasma and MRI biomarkers to discriminate DLB from AD in models combining different types of measures. Specifically, we performed Random Forest analysis including combinations of plasma biomarkers, MRI biomarkers, demographic measures (age, sex, years of education), MMSE, and clinical features (visual hallucinations, parkinsonism, and cognitive fluctuations) as predictors and diagnostic group (DLB vs. AD) as the outcome variable. In these Random Forest models, we report the proportion of importance (Prop imp) as a standard measure of the contribution of each variable to the model´s prediction. Higher prop imp values mean a greater contribution of the variable to the model’s prediction. We also report sensitivity and specificity values separately for each ROC analysis and Random Forest models.</p>
<p id="Par19">All statistical analyses were performed with the SPSS software v.23 and R Studio 4.1.1. Results were considered significant when <em>p</em> ≤ 0.05.</p></section></section><section id="Sec7"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec8"><h3 class="pmc_sec_title">Cohort characteristics</h3>
<p id="Par20">Table <a href="#Tab1" class="usa-link">1</a> describes the key demographic and clinical characteristics of the study participants. There were no statistically significant differences between DLB and AD groups for sex and years of education. DLB patients were significantly younger and the MMSE was significantly higher in DLB, although effect sizes of these differences were small (&lt; 0.2). Group differences in MMSE were no longer significant when controlling for age (<em>p</em> = 0.228).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Key demographic and clinical characteristics of the study participants</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="2" rowspan="1">Variable</th>
<th align="left" colspan="1" rowspan="1">DLB (<em>n</em> = 92)</th>
<th align="left" colspan="1" rowspan="1">AD (<em>n</em> = 43)</th>
<th align="left" colspan="1" rowspan="1">
<em>p</em>-value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="2" rowspan="1">Age, years, median (IQR)</td>
<td align="left" colspan="1" rowspan="1">71 (63, 79)</td>
<td align="left" colspan="1" rowspan="1">75 (69, 81)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.034</strong>
</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">Sex, female, n (%)</td>
<td align="left" colspan="1" rowspan="1">32 (35%)</td>
<td align="left" colspan="1" rowspan="1">18 (42%)</td>
<td align="left" colspan="1" rowspan="1">0.428</td>
</tr>
<tr>
<td align="left" rowspan="4" colspan="1">Years of education, n (%)</td>
<td align="left" colspan="1" rowspan="1">&lt; 9</td>
<td align="left" colspan="1" rowspan="1">18 (21%)</td>
<td align="left" colspan="1" rowspan="1">7 (17.5%)</td>
<td align="left" rowspan="4" colspan="1">0.921</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">9–11</td>
<td align="left" colspan="1" rowspan="1">26 (31%)</td>
<td align="left" colspan="1" rowspan="1">14 (35%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">12–13</td>
<td align="left" colspan="1" rowspan="1">9 (11%)</td>
<td align="left" colspan="1" rowspan="1">5 (12.5%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">&gt; 14</td>
<td align="left" colspan="1" rowspan="1">32 (38%)</td>
<td align="left" colspan="1" rowspan="1">14 (35%)</td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1">MMSE, median (IQR)</td>
<td align="left" colspan="1" rowspan="1">25 (23, 28)</td>
<td align="left" colspan="1" rowspan="1">24 (22, 27)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.044</strong>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p25"><p>Group differences in MMSE were no longer significant when controlling for age (<em>p</em> = 0.228). Bold denotes statistically significant results (<em>p</em> &lt; 0.05). Abbreviations, DLB: Dementia with Lewy Bodies; AD: Alzheimer Disease; IQR: Interquartile range; MMSE: Mini-Mental State Examination</p></div></div></section></section><section id="Sec9"><h3 class="pmc_sec_title">Associations between plasma and MRI biomarkers</h3>
<p id="Par22">Table <a href="#Tab2" class="usa-link">2</a> shows the associations between plasma (GFAP, NfL, Aβ42/40, pTau231, pTau181) and MRI biomarkers (MTA, GCA-F, PA, Fazekas) in DLB and AD, separately. Boxplots for all comparisons can be found in Fig. <a href="#Fig1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Association between plasma and MRI biomarkers</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="2" rowspan="1">MTA</th>
<th align="left" colspan="2" rowspan="1">GCA-F</th>
<th align="left" colspan="2" rowspan="1">PA</th>
<th align="left" colspan="2" rowspan="1">Fazekas</th>
<th align="left" colspan="1" rowspan="1">Group differences (Mann-Whitney U)</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Normal</th>
<th align="left" colspan="1" rowspan="1">Abnormal</th>
<th align="left" colspan="1" rowspan="1">Normal</th>
<th align="left" colspan="1" rowspan="1">Abnormal</th>
<th align="left" colspan="1" rowspan="1">Normal</th>
<th align="left" colspan="1" rowspan="1">Abnormal</th>
<th align="left" colspan="1" rowspan="1">Normal</th>
<th align="left" colspan="1" rowspan="1">Abnormal</th>
<th align="left" colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">DLB</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 59</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 33</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 63</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 29</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 47</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 45</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 55</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 34</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>GFAP</p>
<p>pg/mL, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>101.73</p>
<p>(72.14, 161.83)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>183.68</p>
<p>(142.69, 261.14)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>108.65</p>
<p>(81.25, 174.32)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>180.87</p>
<p>(102.54, 256.46)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>131.16</p>
<p>(72.14, 189.44)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>146.14</p>
<p>(85.19, 195.13)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>103.30</p>
<p>(71.66, 167.44)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>177.32</p>
<p>(110.64, 264.64)</p>
</td>
<td align="left" colspan="1" rowspan="1">a, b,c</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>NfL</p>
<p>pg/mL, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>19.57</p>
<p>(14.51, 27.94)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>29.19</p>
<p>(19.92, 47.70)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>19.58</p>
<p>(14.51, 28.07)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>29.19</p>
<p>(20.00, 35.76)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>19.40</p>
<p>(13.96, 32.34)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>23.55</p>
<p>(17.65, 34.06)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>18.42</p>
<p>(13.96, 26.87)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>27.58</p>
<p>(19.54, 38.55)</p>
</td>
<td align="left" colspan="1" rowspan="1">a, b,c,</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>Aβ42/40</p>
<p>, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.065</p>
<p>(0.058, 0.073)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.057</p>
<p>(0.051, 0.072)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.064</p>
<p>(0.056, 0.075)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.061</p>
<p>(0.055, 0.070)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.066</p>
<p>(0.057, 0.077)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.061</p>
<p>(0.052, 0.068)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.066</p>
<p>(0.058, 0.077)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.059</p>
<p>(0.050, 0.069)</p>
</td>
<td align="left" colspan="1" rowspan="1">c, d</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>pTau231</p>
<p>pg/mL, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>9.75</p>
<p>(7.08, 14.00)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>12.07</p>
<p>(8.84, 16.48)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>9.75</p>
<p>(7.96, 13.77)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>11.69</p>
<p>(8.00, 16.51)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>10.62</p>
<p>(8.28, 14.83)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>9.77</p>
<p>(7.26, 15.87)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>10.27</p>
<p>(7.95, 13.23)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>9.67</p>
<p>(7.86, 15.88)</p>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>pTau181</p>
<p>pg/mL, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13.23</p>
<p>(9.90, 17.65)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>15.01</p>
<p>(12.19, 21.21)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13.47</p>
<p>(10.68, 17.24)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>14.40</p>
<p>(11.14, 23.54)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>14.24</p>
<p>(11.08, 19.93)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13.67</p>
<p>(10.46, 20.39)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13.47</p>
<p>(10.60, 17.24)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>14.66</p>
<p>(11.00, 22.81)</p>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AD</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 24</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 19</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 31</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 12</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 14</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 29</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 25</td>
<td align="left" colspan="1" rowspan="1">
<em>N</em> = 17</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>GFAP</p>
<p>pg/mL, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>168.59</p>
<p>(107.75, 238.53)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>205.66</p>
<p>(143.21, 244.04)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>178.39</p>
<p>(121.79, 225.47)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>187.50</p>
<p>(135.70, 260.29)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>168.59</p>
<p>(118.71, 222.19)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>204.76</p>
<p>(132.94, 243.80)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>165.07</p>
<p>(97.34, 214.93)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>220.08</p>
<p>(173.10, 254.87)</p>
</td>
<td align="left" colspan="1" rowspan="1">c</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>NfL</p>
<p>pg/mL, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>25.48</p>
<p>(17.92, 36.80)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>28.00</p>
<p>(21.79, 34.79)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>27.93</p>
<p>(18.56, 34.46)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>27.65</p>
<p>(18.09, 36.81)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>23.40</p>
<p>(16.51, 32.59)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>27.93</p>
<p>(22.00, 37.22)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>23.03</p>
<p>(17.73, 35.80)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>30.09</p>
<p>(24.63, 35.56)</p>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Aβ42/40, median (IQR)</td>
<td align="left" colspan="1" rowspan="1">
<p>0.059</p>
<p>(0.052, 0.063)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.053</p>
<p>(0.048, 0.062)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.059</p>
<p>(0.052, 0.063)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.051</p>
<p>(0.047, 0.060)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.059</p>
<p>(0.047, 0.063)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.056</p>
<p>(0.050, 0.064)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.059</p>
<p>(0.050, 0.063)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>0.058</p>
<p>(0.049, 0.064)</p>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>pTau231</p>
<p>pg/mL, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>14.25</p>
<p>(10.34, 18.37)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13.69</p>
<p>(9.74, 19.99)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>14.71</p>
<p>(10.84, 19.43)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>12.45</p>
<p>(9.08, 17.44)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>14.66</p>
<p>(10.98, 18.22)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>13.83</p>
<p>(10.21, 19.80)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>14.71</p>
<p>(10.51, 19.80)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>12.47</p>
<p>(7.88, 15.36)</p>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>pTau181</p>
<p>pg/mL, median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>19.62</p>
<p>(15.98, 22.69)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>22.23</p>
<p>(17.68, 29.49)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>20.38</p>
<p>(17.10, 27.31)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>19.49</p>
<p>(12.58, 26.38)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>20.53</p>
<p>(15.01, 24.19)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>20.18</p>
<p>(16.44, 27.11)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>20.68</p>
<p>(16.35, 26.78)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>19.62</p>
<p>(14.39, 26.30)</p>
</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p207"><p>The table shows medians (interquartile range) for each plasma biomarker separately for patients with normal versus abnormal MRI markers, stratified by DLB and AD groups. a: p-value &lt; 0.05 for MTA; b: p-value &lt; 0.05 for GCA-F; c: p-value &lt; 0.05 for Fazekas; d: p-value &lt; 0.05 for PA. Abbreviations, MTA: medial temporal lobe atrophy; GCA-F: global cortical atrophy scale – frontal subscale; PA: posterior atrophy; DLB: Dementia with Lewy Bodies; AD: Alzheimer Disease; GFAP: glial fibrillary acidic protein; NfL: neurofilament light; Aβ42/40: amyloid β 1–42/ amyloid β 1–40 ratio; pTau231: phosphorylated Tau 231; pTau181: phosphorylated Tau 181</p></div></div></section><figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374387_13195_2025_1848_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642e/12374387/708dd1b4205d/13195_2025_1848_Fig1_HTML.jpg" loading="lazy" id="d33e1242" height="744" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Box plots for levels of plasma biomarkers in DLB and AD patients stratified by normal vs. abnormal MRI visual ratings. *: p-value &lt; 0.05 (Mann-Whitney test). Abbreviations, MTA: medial temporal lobe atrophy; GCA-F: global cortical atrophy scale – frontal subscale; PA: posterior atrophy; DLB: Dementia with Lewy Bodies; AD: Alzheimer Disease; GFAP: glial fibrillary acidic protein; NfL: neurofilament light; Aβ42/40: amyloid β 1–42/ amyloid β 1–40 ratio; pTau231: phosphorylated Tau 231; pTau181: phosphorylated Tau 181</p></figcaption></figure><p id="Par25">In the DLB group, GFAP and NfL levels were higher in patients with more atrophy in medial temporal lobe (i.e. MTA) and frontal lobe (GCA-F), and a higher cerebrovascular lesion load (Fazekas). Moreover, the Aβ42/40 ratio was lower in DLB patients with more posterior atrophy (PA) and a higher cerebrovascular lesion load (Fazekas). In contrast, pTau231 and pTau181 were not significantly associated with any of the MRI measures.</p>
<p id="Par26">In the AD group, GFAP levels were higher in patients with a higher cerebrovascular lesion load (Fazekas). Given the smaller size of the AD group compared to the DLB group, we considered effect sizes alongside p-values. Supplementary Table <a href="#MOESM1" class="usa-link">1</a> shows a high consistency between p-values and effect sizes. In the AD group, we observed small effect sizes for the following non-statistically significant associations: higher NfL levels with greater cerebrovascular lesion load (Fazekas) (<em>p</em> = 0.093, ES = 0.26), lower pTau231 levels with greater cerebrovascular lesion load (Fazekas) (<em>p</em> = 0.104, ES=-0.25), and lower Aβ42/40 levels with increased frontal atrophy (GCA-F) (<em>p</em> = 0.165, ES=-0.21) (Supplementary Table <a href="#MOESM1" class="usa-link">1</a>).</p></section><section id="Sec10"><h3 class="pmc_sec_title">Plasma biomarkers across atrophy subtypes in DLB</h3>
<p id="Par27">Figure <a href="#Fig2" class="usa-link">2</a> and Supplementary Table <a href="#MOESM1" class="usa-link">2</a> display the levels of plasma biomarkers across atrophy subtypes (typical AD, limbic predominant, hippocampal-sparing, and minimal-atrophy subtypes) in the DLB group. No differences were found for sex (<em>p</em> = 0.738) and MMSE (<em>p</em> = 0.154) across atrophy subtypes. However, subtypes differed significantly on age (<em>p</em> &lt; 0.001), being minimal atrophy participants younger than typical AD.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374387_13195_2025_1848_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/642e/12374387/f9ecba7127fc/13195_2025_1848_Fig2_HTML.jpg" loading="lazy" id="d33e1290" height="548" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Box-plots for plasma biomarker levels across atrophy subtypes in DLB. *: p-value &lt; 0.005 (Kruskal-Wallis test with the Bonferroni correction). Abbreviations, GFAP: glial fibrillary acidic protein; NfL: neurofilament light; Aβ42/40: amyloid β 1–42/ amyloid β 1–40 ratio; pTau231: phosphorylated Tau 231; pTau181: phosphorylated Tau 181; AD: Alzheimer Disease</p></figcaption></figure><p id="Par29">We observed statistically significant differences across atrophy subtypes for GFAP, NfL, and Aβ42/40. Specifically, the typical-AD subtype showed higher levels than the hippocampal-sparing and minimal atrophy subtypes for GFAP (<em>p</em> &lt; 0.001, <em>p</em> &lt; 0.001, respectively) and NfL levels (<em>p</em> = 0.035, <em>p</em> &lt; 0.001). In addition, the minimal atrophy subtype showed higher Aβ42/40 levels compared with the hippocampal-sparing and the typical AD subtype. When repeating all these analyses correcting for age in ANCOVA, we obtained similar results (Supplementary Table <a href="#MOESM1" class="usa-link">2</a>).</p></section><section id="Sec11"><h3 class="pmc_sec_title">The ability of plasma and MRI biomarkers to discriminate DLB from AD</h3>
<p id="Par30">Table <a href="#Tab3" class="usa-link">3</a> and Supplementary Fig. <a href="#MOESM1" class="usa-link">1</a> show the ability of plasma and MRI biomarkers to discriminate DLB from AD. Specifically, Table <a href="#Tab3" class="usa-link">3</a> first shows group differences and AUC values, with p-values obtained without any correction. This is followed by group differences and AUC values with p-values obtained with a correction for age and MMSE.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>The ability of plasma and MRI biomarkers to discriminate DLB from AD</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">DLB (<em>n</em> = 92)</th>
<th align="left" colspan="1" rowspan="1">AD (<em>n</em> = 43)</th>
<th align="left" colspan="1" rowspan="1">Group differences from Mann-Whitney U/Chi square. <em>p</em>-value</th>
<th align="left" colspan="1" rowspan="1">Discrimination of DLB from AD. AUC-ROC<br>(<em>p</em>-value)</th>
<th align="left" colspan="1" rowspan="1">Group differences from ANCOVA (Age- and MMSE-corrected results).<br><em>p</em>-value</th>
<th align="left" colspan="1" rowspan="1">Discrimination of DLB from AD (Age- and MMSE-corrected results). AUC-ROC (<em>p</em>-value)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>GFAP</p>
<p>pg/mL,</p>
<p>median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">133 (82, 188)</td>
<td align="left" colspan="1" rowspan="1">178 (133, 243)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.007</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.66 (<strong>0.001</strong>)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.53 (0.607)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>NfL</p>
<p>pg/mL,</p>
<p>median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">22 (16, 33)</td>
<td align="left" colspan="1" rowspan="1">28 (18, 35)</td>
<td align="left" colspan="1" rowspan="1">0.083</td>
<td align="left" colspan="1" rowspan="1">0.60 (0.068)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.51 (0.856)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Aβ42/40</td>
<td align="left" colspan="1" rowspan="1">0.063 (0.055, 0.073)</td>
<td align="left" colspan="1" rowspan="1">0.058 (0.050, 0.063)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.002</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.67 <strong>(&lt; 0.001</strong>)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.003</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.51 (0.894)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>pTau231</p>
<p>pg/mL,</p>
<p>median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">10 (8, 15)</td>
<td align="left" colspan="1" rowspan="1">14 (10, 19)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.004</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.66 (<strong>0.002</strong>)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.002</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.50 (0.607)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>pTau181</p>
<p>pg/mL,</p>
<p>median (IQR)</p>
</td>
<td align="left" colspan="1" rowspan="1">14 (11, 20)</td>
<td align="left" colspan="1" rowspan="1">20 (16, 27)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.72 (<strong>&lt; 0.001</strong>)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.020</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.55 (0.401)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>MTA</p>
<p>(positive, n (%))</p>
</td>
<td align="left" colspan="1" rowspan="1">33 (35.9%)</td>
<td align="left" colspan="1" rowspan="1">19 (44.2%)</td>
<td align="left" colspan="1" rowspan="1">0.355</td>
<td align="left" colspan="1" rowspan="1">0.55 (0.414)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.015</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.58 (0.183)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GCA-F (positive, n (%))</td>
<td align="left" colspan="1" rowspan="1">29 (31.5%)</td>
<td align="left" colspan="1" rowspan="1">12 (27.9%)</td>
<td align="left" colspan="1" rowspan="1">0.670</td>
<td align="left" colspan="1" rowspan="1">0.49 (0.846)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.004</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.51 (0.891)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<p>PA</p>
<p>(positive, n (%))</p>
</td>
<td align="left" colspan="1" rowspan="1">45 (48.9%)</td>
<td align="left" colspan="1" rowspan="1">29 (67.4%)</td>
<td align="left" colspan="1" rowspan="1">
<strong>0.044</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.59 (0.113)</td>
<td align="left" colspan="1" rowspan="1">0.152</td>
<td align="left" colspan="1" rowspan="1">0.66 (<strong>0.004</strong>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Fazekas (positive, n (%))</td>
<td align="left" colspan="1" rowspan="1">34 (37%)</td>
<td align="left" colspan="1" rowspan="1">17 (39.5%)</td>
<td align="left" colspan="1" rowspan="1">0.803</td>
<td align="left" colspan="1" rowspan="1">0.52 (0.779)</td>
<td align="left" colspan="1" rowspan="1">
<strong>&lt; 0.001</strong>
</td>
<td align="left" colspan="1" rowspan="1">0.50 (0.973)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p235"><p>Medians and interquartile ranges reported for DLB and AD, without any correction. MRI biomarkers were dichotomized as normal and abnormal. Bold denotes statistically significant results (<em>p</em> &lt; 0.05). Abbreviations, DLB: Dementia with Lewy Bodies; AD: Alzheimer Disease; GFAP: glial fibrillary acidic protein; NfL: neurofilament light; Aβ42/40: amyloid β 1–42/ amyloid β 1–40 ratio; pTau231: phosphorylated Tau 231; pTau181: phosphorylated Tau 181; MTA: medial temporal lobe atrophy; GCA-F: global cortical atrophy scale – frontal subscale; PA: posterior atrophy</p></div></div></section><section id="Sec12"><h4 class="pmc_sec_title">Plasma biomarkers alone</h4>
<p id="Par32">All plasma biomarkers showed lower levels in DLB compared to AD patients, except for the Aβ42/40 ratio where AD patients showed lower levels. Group differences were all statistically significant when correcting for age and MMSE.</p>
<p id="Par33">ROC analyses for each plasma biomarker individually generally showed moderate AUC values, with plasma pTau181 achieving the highest discriminatory performance (AUC 0.72, <em>p</em> &lt; 0.001) without any correction. However, the correction for age and MMSE influenced AUC values substantially, with none of the plasma biomarkers discriminating DLB from AD better than chance (<em>p</em> &gt; 0.05).</p></section><section id="Sec13"><h4 class="pmc_sec_title">Plasma biomarkers combined</h4>
<p id="Par34">We next combined all plasma biomarkers using Random Forest analysis. The model achieved an accuracy of 74.2%. Including age, sex, years of education, and MMSE in the Random Forest model did not improve the discriminatory ability (accuracy 74.6%). The five most relevant variables in the discrimination between DLB and AD were plasma biomarkers pTau181, Aβ42/40 ratio, and pTau231, followed by age and MMSE (supplementary Table <a href="#MOESM1" class="usa-link">3</a>).</p></section><section id="Sec14"><h4 class="pmc_sec_title">MRI biomarkers alone</h4>
<p id="Par35">Regarding group differences for MRI markers, prior correction, there were only statistically significant differences in PA, with a higher proportion of AD patients showing an abnormal score in PA as compared with DLB patients.</p>
<p id="Par36">None of the MRI measures (MTA, GCA-F, PA, Fazekas) achieved a statistically significant ability to discriminate the two groups prior correction. However, when correcting for age and MMSE, ROC analysis showed that PA could significantly discriminate between DLB and AD (AUC 0.66, <em>p</em> = 0.004).</p></section><section id="Sec15"><h4 class="pmc_sec_title">MRI biomarkers combined</h4>
<p id="Par37">When combining all MRI biomarkers among them and with demographic variables and MMSE using Random Forest, the model provided an accuracy of 61.0%. MTA and PA were the most contributing variables to the model. However, MRI biomarkers alone without demographic variables and MMSE could not generate a reliable model.</p></section></section><section id="Sec16"><h3 class="pmc_sec_title">Combination of plasma and MRI biomarkers with core clinical features to discriminate DLB from AD</h3>
<p id="Par38">Finally, we evaluated the ability of plasma and MRI biomarkers to improve the ability of core clinical features (visual hallucinations, parkinsonism, and cognitive fluctuations) to discriminate DLB from AD. These analyses were based on recurrent Random Forest models combining different type of measures (Table <a href="#Tab4" class="usa-link">4</a>). The combination of core clinical features reached an accuracy of 81.8% to discriminate DLB from AD, with a high sensitivity (88.2%) but a low specificity (67.7%). The Random Forest adding MRI biomarkers to the core clinical features provided a similar accuracy (81.6%). PA was the MRI measure achieving the highest importance in the model. On the contrary, the model adding plasma biomarkers to the core clinical features did increase the accuracy (86.6%), with a notable increase of the specificity (78.6%). The Aβ42/40 ratio was the plasma biomarker achieving the highest importance in the model. Adding MRI biomarkers to the model with core clinical features and plasma biomarkers did not change these last results substantially (accuracy = 85.4%, specificity = 79.2%).</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Core clinical features, plasma biomarkers, and MRI visual ratings for the discrimination of DLB from AD</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1">
<em>N</em>
</th>
<th align="left" colspan="1" rowspan="1">Accuracy<br>(95% CI)</th>
<th align="left" colspan="1" rowspan="1">Sensitivity<br>(95% CI)</th>
<th align="left" colspan="1" rowspan="1">Specificity<br>(95% CI)</th>
<th align="left" colspan="1" rowspan="1">Variables contribution (proportion importance)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical features</td>
<td align="left" colspan="1" rowspan="1">96</td>
<td align="left" colspan="1" rowspan="1">
<p>81.8</p>
<p>(73.1, 88.2)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>88.2</p>
<p>(78.5, 93.9)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>67.7</p>
<p>(50.1, 81.4)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Visual hallucinations: 25.33</p>
<p>Parkinsonism: 18.24</p>
<p>Cognitive fluctuations: 14.74</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical features + MRI</td>
<td align="left" colspan="1" rowspan="1">98</td>
<td align="left" colspan="1" rowspan="1">
<p>81.6</p>
<p>(72.8, 88.1)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>85.1</p>
<p>(75.3, 91.5)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>70.8</p>
<p>(50.8, 85.1)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Parkinsonism: 73.08</p>
<p>Visual hallucinations: 49.10</p>
<p>PA: 38.86</p>
<p>Cognitive fluctuations: 27.05</p>
<p>Fazekas: 16.50</p>
<p>MTA: 14.46</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical features + Plasma</td>
<td align="left" colspan="1" rowspan="1">97</td>
<td align="left" colspan="1" rowspan="1">
<p>86.6</p>
<p>(78.4, 92.0)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>89.9</p>
<p>(80.5, 95.0)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>78.6</p>
<p>(60.5, 89.8)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Parkinsonism: 19.03</p>
<p>Aβ42/40: 18.96</p>
<p>Visual hallucinations: 14.67</p>
<p>Cognitive fluctuations: 9.75</p>
<p>pTau181: 8.47</p>
<p>GFAP: 4.59</p>
<p>NfL: 0.48</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical features + Plasma + MRI</td>
<td align="left" colspan="1" rowspan="1">96</td>
<td align="left" colspan="1" rowspan="1">
<p>85.4</p>
<p>(77.0, 91.1)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>87.5</p>
<p>(77.9, 93.3)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>79.2</p>
<p>(59.5, 90.8)</p>
</td>
<td align="left" colspan="1" rowspan="1">
<p>Parkinsonism: 62.38</p>
<p>Ratio Aβ42/40: 54.42</p>
<p>Visual hallucinations: 44.77</p>
<p>Cognitive fluctuations: 33.17</p>
<p>pTau181: 28.84</p>
<p>GFAP: 14.68</p>
<p>pTau231: 12.76</p>
<p>PA: 8.03</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p293"><p>Abbreviations, MRI: magnetic resonance imaging; MTA: medial temporal lobe atrophy; PA: posterior atrophy; GFAP: glial fibrillary acidic protein; NfL: neurofilament light; Aβ42/40: amyloid β 1–42/ amyloid β 1–40 ratio; pTau231: phosphorylated Tau 231; pTau181: phosphorylated Tau 181; CI = confidence interval</p></div></div></section></section></section><section id="Sec17"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par40">This study investigated the association between plasma biomarkers and MRI markers of brain atrophy and CVD in DLB patients compared with AD patients, and tested the ability of plasma and MRI biomarkers to discriminate DLB from AD. The main finding was the significant association of plasma biomarkers of glial activity (i.e., GFAP) and neurodegeneration (i.e. NfL) with atrophy in frontal and medial temporal brain areas as well as CVD in DLB; and the association of amyloid-related pathology biomarkers with atrophy in posterior brain areas and CVD in DLB. These associations were not replicated in the AD group in our study. Plasma biomarkers helped improve the low specificity of core clinical features in discriminating DLB from AD, which may have implications for clinical practice.</p>
<p id="Par41">Our first aim was to investigate the association of plasma biomarkers with MRI markers of neurodegeneration and CVD co-pathology in DLB, and compare the findings with the associations found in AD. In the DLB group, we found that higher plasma levels of GFAP and NfL were associated with greater brain atrophy in medial temporal and frontal brain areas as well as with a higher cerebrovascular lesion load (Fazekas). GFAP is a biomarker of astrocyte activation while NfL is a biomarker of axonal damage. Astrocyte activation and axonal damage can be caused by diverse pathological processes and so, GFAP and NfL are considered as unspecific biomarkers of neuroinflammation and neurodegeneration, respectively [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Previous studies showed the association of brain atrophy with neuroinflammation and unspecific neurodegeneration as assessed with serum and plasma GFAP and NfL in patients with different brain diseases (i.e. traumatic brain injury, multiple sclerosis, etc.) [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>–<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. Hence, our current study adds to that literature by demonstrating that the association of brain atrophy with plasma GFAP and NfL also exists in DLB patients. Regarding CVD co-pathology, higher levels of plasma GFAP and NfL were associated with abnormal Fazekas scores in our study. GFAP and NfL have been associated with vascular pathology, suggesting that neuroinflammation may be a key contributor to this association in patients with AD and vascular disease [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Further, a previous study reported higher levels of NfL to be associated with brain atrophy and vascular disease in elderly populations with and without cognitive impairment [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Our study extends the previous literature by showing similar associations in the DLB population. In our study, most of the associations discussed above were not statistically significant in AD patients, except for the association of plasma GFAP with cerebrovascular lesion load (Fazekas). Our AD group was selected to be comparable in sex to the DLB group, leading to an AD group with more men than usual. That approach makes our AD group a good control for our DLB group, but it may not completely represent AD groups in previous studies, hence the different results [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>].</p>
<p id="Par42">We found that DLB patients with lower plasma levels of Aβ42/40 had greater brain atrophy in posterior brain areas as well as a higher cerebrovascular lesion load. By contrast, we did not find any statistically significant association between pTau plasma biomarkers and MRI markers of atrophy or CVD. A previous study suggested that atrophy in posterior brain areas is the signature atrophy of DLB [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>], although atrophy in posterior brain areas may be exacerbated by amyloid and tau co-pathology as assessed with CSF biomarkers [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. A recent study showed an association of Aβ but not tau with α-synuclein in the CSF [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Hence, the association between posterior atrophy and plasma Aβ42/40 in DLB in our current study could reflect the previously shown contribution of amyloid co-pathology towards posterior brain atrophy, perhaps jointly with α-synuclein-related pathology. Previous studies described an association between plasma pTau181 and brain atrophy in AD patients [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. The absence of significant associations for pTau biomarkers in DLB in our study could be explained by the relatively low proportion of DLB patients with tau pathology, which is around 30% of cases [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Another possible explanation is that the contribution of tau co-pathology towards posterior brain atrophy in DLB is less prominent than that of α-syn (and possible amyloid). We found no association between plasma biomarkers of Aβ and MTA, while previous studies showed significant associations between CSF biomarkers of Aβ and MTA both in DLB and AD [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>, <a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. A possible explanation is that the contribution of AD co-pathology towards MTA in DLB patients may be captured with CSF biomarkers but not plasma biomarkers [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>].</p>
<p id="Par43">Our second aim was to compare plasma biomarkers across atrophy subtypes in DLB. The motivation for these analyses was to further understand the biological underpinnings of the MRI subtypes previously reported in DLB [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>], but also to further assess the potential contributions of AD co-pathology towards the neurodegeneration in DLB. This was particularly relevant in the context of the typical AD atrophy pattern, which is the most common in AD [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. The only previous study that investigated these subtypes in DLB did not report plasma or CSF biomarkers [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. The finding of lower Aβ42/40 in typical AD and hippocampal-sparing subtypes compared with the minimal atrophy subtype could reflect the contribution of amyloid co-pathology to these different phenotypes in DLB. In addition, GFAP and NfL showed higher levels in typical AD compared with hippocampal-sparing and minimal atrophy subtypes, which is in line with the widespread and severe neurodegeneration in the typical AD subtype [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Previous studies reported the expression of GFAP in pyramidal neurons of the hippocampus in AD [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. The typical AD subtype has the most severe hippocampal atrophy, but the hippocampus is spared in both minimal atrophy and hippocampal-sparing subtypes [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Our finding of higher GFAP levels in typical AD could thus reflect the activity of hippocampal neurons.</p>
<p id="Par44">Our last aim was to assess the ability of plasma and MRI biomarkers to discriminate between DLB and AD. We started with individual biomarkers. The best individual diagnostic discriminations were observed for plasma pTau181, which achieved an AUC of 0.72 when not corrected for age or MMSE, and the MRI scale for posterior brain atrophy (PA), with an AUC of 0.66. Previous studies evaluated the ability of plasma pTau181, NfL, and GFAP to discriminate among different dementias [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. These studies found the best accuracies for pTau181 in the discrimination between DLB and AD, while MRI markers were not included. However, a previous study highlighted the importance of correcting these analyses for the effect of variables such as age [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. Indeed, we found that the ability of plasma biomarkers to discriminate DLB from AD changed considerably when correcting for age (and global cognitive status). In the clinical context, the age of the patient is routinely considered into the diagnostic procedure by clinicians. Therefore, we provided the data prior and after correction for age (and global cognitive status), to inform on the effect of age in our data. For example, for MRI markers, PA showed a substantial increase in its ability to discriminate DLB from AD after the correction for age (and MMSE). This could be related to the finding that PA may be unable to differentiate DLB from AD at older ages [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. A finding that deserves further investigation is that MTA did not show a significant AUC in our study, despite MTA being traditionally regarded as an important MRI marker to differentiate DLB from AD [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Our study lacked neuropathological confirmation and thus, DLB cases with AD co-pathology may have obscured AUC values for MTA.</p>
<p id="Par45">We next continued with combinations of biomarkers with themselves and with clinical features. A previous study found that the combination of three atrophy measures (i.e. MTA, GCA-F, PA) and Fazekas improved the accuracy obtained for MTA alone in discriminating DLB from AD [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>]. In our study, MRI and plasma biomarkers showed a rather limited ability to discriminate DLB from AD individually. However, we found that plasma biomarkers improved baseline diagnostic performance of core clinical features substantially. Specifically, core clinical features of parkinsonism, visual hallucinations, and cognitive fluctuations discriminated DLB from AD with an accuracy of 82% in our study. Sensitivity was 88% but specificity was low (68%). Importantly, plasma biomarkers increased the accuracy up to 87%, mostly positively influencing specificity (increase from 68% up to 79%) without compromising sensitivity (90%). The plasma biomarkers contributing the highest to the discrimination were the Aβ42/40 ratio followed by pTau181, GFAP and NFL. Of note, while parkinsonism was the most discriminating feature, the Aβ42/40 ratio had a higher contribution to the model above and beyond other core clinical features such as visual hallucinations and cognitive fluctuations. The specificity of 79% achieved by this model is superior than the specificity reported in other studies for DLB supportive biomarkers such as FDG-PET (74% specificity) [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. On the contrary, including MRI in these models did not improve the discrimination of DLB from AD. Altogether, our data suggest that MRI and plasma biomarkers may not aid the discrimination between DLB and AD by themselves, but plasma biomarkers may make a substantial impact to the specificity of core clinical features in the differential diagnosis between these two common neurodegenerative dementias. Since plasma biomarkers are expected to be implemented soon in the clinical routine, this finding may have some clinical implications. A first screening for core clinical features of DLB along with plasma biomarkers may help the subsequent patient flow in specialized clinics, possibly reducing the common delay in DLB diagnosis.</p>
<p id="Par46">This study has some limitations. Firstly, the sample size was smaller for the AD group than for the DLB group, which mostly involves the associations reported in Table <a href="#Tab2" class="usa-link">2</a>. Although this study focused primarily on DLB, the smaller size of the AD group could have led to obtain less significant associations for the AD patients. To handle this issue, we inspected effect sizes in addition to p-values and concluded that the lower number of statistically significant associations in the AD group does not seems to be explained by its smaller group size. Secondly, this study relied on clinical diagnosis, while we did not have access to CSF or PET biomarkers, validated plasma cut-offs for the pTau/Aβ42 ratio, or neuropathological diagnostic confirmation. Therefore, we could not stratify the DLB group based on AD biomarkers. This limits the possibility to distinguish between “pure” DLB and mixed DLB-AD profiles, which could potentially influence the reported associations between plasma biomarkers and MRI measures. The focus of this study on plasma biomarkers however provides some insight into the underlying pathophysiology. Thirdly, RBD is an important core clinical feature in the 2017 update of the diagnostic criteria for DLB [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. However, RBD data was not available in our study and was not included in the Random Forest models. Previous publications showed that the addition of RBD primarily increased the lower sensitivity of the 2005 diagnostic criteria [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>, <a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. Hence, the lack of RBD data in our study may have had a minor impact since the sensitivity of the remaining core clinical features was rather high (i.e. 88.2%). Finally, the age differences between the DLB and AD groups may make results interpretation difficult. However, we leveraged this situation as it may reflect actual differences found in clinical practice, which often contribute to diagnostic decisions. In clinical practice, DLB patients are often younger than AD patients, like in our study. Hence, this finding may increase the representativity and clinical generalization of our results. By reporting uncorrected and age-corrected results we elaborated on the impact of age on the discrimination between DLB and AD groups, which is a topic that has not been documented enough in previous studies. The age also reflects time and disease progression and, therefore, the age is biologically involved in the disease process we are investigating instead of just being a mere confounder.</p></section><section id="Sec18"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par47">This study demonstrates that plasma biomarkers of AD co-pathology, glial processes and unspecific neurodegeneration partly explain the brain atrophy and cerebrovascular disease-related neurodegeneration observed in DLB patients. While the investigated plasma and MRI biomarkers may not resolve the differential diagnosis between DLB and AD by themselves, the combination of plasma biomarkers with core clinical features helped increase the diagnostic specificity from 68% up to 79%, with a sensitivity of 90%. Including plasma biomarkers in the clinical work-up may help expediting the referral of patients for specialized assessment and, thus, reduce delays in DLB diagnosis.</p></section><section id="Sec19"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12374387/bin/13195_2025_1848_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (34KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>CPB acknowledges a predoctoral “PFIS” FI20/00022 and mobility “M-AES” MV21/00007 grants from the Health Institute Carlos III, and postdoctoral grant “CIAPOS/2023/153” from Consellería de Innovación, Universidades, Ciencia y Sociedad digital, Generalitat Valenciana.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>Aβ</dt>
<dd><p id="Par55">Amyloid β</p></dd>
<dt>AD</dt>
<dd><p id="Par56">Alzheimer’s Disease</p></dd>
<dt>CT</dt>
<dd><p id="Par57">Computed Tomography</p></dd>
<dt>CVD</dt>
<dd><p id="Par58">Cerebrovascular disease</p></dd>
<dt>CSF</dt>
<dd><p id="Par59">Cerebrospinal Fluid</p></dd>
<dt>DaTSCAN</dt>
<dd><p id="Par60">Dopamine transporter Scan</p></dd>
<dt>DLB</dt>
<dd><p id="Par61">Dementia with Lewy Bodies</p></dd>
<dt>GCA-F</dt>
<dd><p id="Par62">Global Cortical Atrophy scale – Frontal subscale</p></dd>
<dt>GFAP</dt>
<dd><p id="Par63">Glial Fibrillary Acidic Protein</p></dd>
<dt>MIBG</dt>
<dd><p id="Par64">123Iodine-metaiodobenzylguanidine</p></dd>
<dt>MMSE</dt>
<dd><p id="Par65">Mini-Mental State Examination</p></dd>
<dt>MRI</dt>
<dd><p id="Par66">Magnetic Resonance Imaging</p></dd>
<dt>MTA</dt>
<dd><p id="Par67">Medial Temporal lobe Atrophy</p></dd>
<dt>NfL</dt>
<dd><p id="Par68">Neurofilament Light</p></dd>
<dt>PA</dt>
<dd><p id="Par69">Posterior Atrophy</p></dd>
<dt>PET</dt>
<dd><p id="Par70">Positron Emission Tomography</p></dd>
<dt>p-Tau</dt>
<dd><p id="Par71">Phosphorylated Tau</p></dd>
<dt>RBD</dt>
<dd><p id="Par72">Rapid eye movement sleep Behaviour Disorder</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>CPB: Drafting/revision of the manuscript, study concept or design, analysis or interpretation of data; KB: Drafting/revision of the manuscript, major role in the acquisition of data; MCG: Drafting/revision of the manuscript, major role in the acquisition of data; NJA: Drafting/revision of the manuscript, analysis or interpretation of data; DA: Drafting/revision of the manuscript, major role in the acquisition of data; HZ: Drafting/revision of the manuscript, analysis or interpretation of data; EW: Drafting/revision of the manuscript, major role in the acquisition of data; OB: Drafting/revision of the manuscript, major role in the acquisition of data; FB: Drafting/revision of the manuscript, major role in the acquisition of data; CT: Drafting/revision of the manuscript, major role in the acquisition of data; AL: Drafting/revision of the manuscript , major role in the acquisition of data; CCP: Drafting/revision of the manuscript, analysis or interpretation of data; MB: Drafting/revision of the manuscript, analysis or interpretation of data; DF: Drafting/revision of the manuscript, study concept or design, analysis or interpretation of data.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open access funding provided by Karolinska Institute. DF receives funding from the Swedish Research Council (Vetenskapsrådet, grant 2022 − 00916), the Center for Innovative Medicine (CIMED, grants 20200505 and FoUI-988826), the regional agreement on medical training and clinical research of Stockholm Region (ALF Medicine, grants FoUI-962240 and FoUI-987534), the Swedish Brain Foundation (Hjärnfonden FO2023-0261, FO2022-0175, FO2021-0131), the Swedish Alzheimer Foundation (Alzheimerfonden AF-968032, AF-980580, AF-994058, AF-1010553), the Swedish Dementia Foundation (Demensfonden), the Gamla Tjänarinnor Foundation, the Gun och Bertil Stohnes Foundation, the Åke Wiberg Foundation, StratNeuro, Funding for Research from Karolinska Institutet, Neurofonden, and the Foundation for Geriatric Diseases at Karolinska Institutet, as well as contributions from private bequests. EW was supported by the Swedish Research Council (VR) 2016–02282, 2021 − 01861, the Center for Innovative Medicine (CIMED) FoUI-954459, FoUI-975174, the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet FoUI-954893, FoUI-986083, The Swedish Brain Foundation (Hjärnfonden) FO2025-0214, FO2022-0084, FO2024-0239, The Swedish Alzheimer’s Foundation (Alzheimerfonden) AF-980387, AF-993856, AF-1011590 The Swedish Parkinson’s foundation (Parkinsonfonden) 1521/23, 1557/24, King Gustaf V: s and Queen Victorias Foundation, and Olle Engkvists Foundation (Olle Engkvists Stiftelse) 186–0660, 224 − 0069, Swedish Dementia Foundation (Demensfonden), as well as Birgitta and Sten Westerberg for additional financial support.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par48">Informed consent on participation was obtained from all patients or a surrogate according to the Declaration of Helsink, and the study was approved by the ethical committee of each participating center.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par49">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par50">D. Aarsland reports receiving research support and/or honoraria from AstraZeneca, H. Lundbeck, Novartis Pharmaceuticals, Biogen, Evonik, Sanofi, Roche, and GE Health and serving as a paid consultant for H. Lundbeck, Eisai, Heptares, and Mentis Cura. H. Zetterberg has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). C.E. Teunissen has a collaboration contract with ADx Neurosciences, Quanterix, and Eli Lilly, performed contract research or received grants from AC-Immune, Axon Neurosciences, BioConnect, Bioorchestra, Brainstorm Therapeutics, Celgene, EIP Pharma, Eisai, Fujirebio, Grifols, Instant Nano Biosensors, Merck, Novo Nordisk, PeopleBio, Roche, Siemens, Toyama, and Vivoryon. She is an editor of Alzheimer Research and Therapy, and serves on editorial boards of Medidact Neurologie/Springer, and Neurology: Neuroimmunology &amp; Neuroinflammation. She had speaker contracts for Roche, Grifols, Novo Nordisk. D. Ferreira consults for BioArctic and has received honoraria from Esteve. The remaining co-authors report no disclosures relevant to the manuscript.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Mayo M, Bordelon Y. Dementia with lewy bodies. Semin Neurol. 2014;34:182–8.
</cite> [<a href="https://doi.org/10.1055/s-0034-1381741" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24963677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mayo%20M,%20Bordelon%20Y.%20Dementia%20with%20lewy%20bodies.%20Semin%20Neurol.%202014;34:182%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Erkkinen MG, Kim M-O, Geschwind MD. Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2018;10:a033118.
</cite> [<a href="https://doi.org/10.1101/cshperspect.a033118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5880171/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28716886/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Erkkinen%20MG,%20Kim%20M-O,%20Geschwind%20MD.%20Clinical%20neurology%20and%20epidemiology%20of%20the%20major%20neurodegenerative%20diseases.%20Cold%20Spring%20Harb%20Perspect%20Biol.%202018;10:a033118." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Vermunt L, Doelkahar BS, Peeters CFW, van de Beek M, Visser PJ, Tijms BM, et al. Dementia with lewy bodies (DLB) with amyloid co-pathology has a distinct CSF proteomics profile compared to pure DLB and alzheimer disease. Volume 17. Alzheimer’s &amp; Dementia; 2021.</cite>
</li>
<li id="CR4">
<span class="label">4.</span><cite>McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor J-P, Weintraub D, et al. Diagnosis and management of dementia with lewy bodies. Neurology. 2017;89:88–100.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000004058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5496518/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28592453/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?McKeith%20IG,%20Boeve%20BF,%20Dickson%20DW,%20Halliday%20G,%20Taylor%20J-P,%20Weintraub%20D,%20et%20al.%20Diagnosis%20and%20management%20of%20dementia%20with%20lewy%20bodies.%20Neurology.%202017;89:88%E2%80%93100." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Bousiges O, Blanc F. Biomarkers of dementia with lewy bodies: differential diagnostic with alzheimer’s disease. Int J Mol Sci. 2022;23:6371.
</cite> [<a href="https://doi.org/10.3390/ijms23126371" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9223587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35742814/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bousiges%20O,%20Blanc%20F.%20Biomarkers%20of%20dementia%20with%20lewy%20bodies:%20differential%20diagnostic%20with%20alzheimer%E2%80%99s%20disease.%20Int%20J%20Mol%20Sci.%202022;23:6371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Oppedal K, Ferreira D, Cavallin L, Lemstra AW, ten Kate M, Padovani A, et al. A signature pattern of cortical atrophy in dementia with lewy bodies: A study on 333 patients from the European DLB consortium. Alzheimer’s Dement. 2019;15:400–9.
</cite> [<a href="https://doi.org/10.1016/j.jalz.2018.09.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30439333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oppedal%20K,%20Ferreira%20D,%20Cavallin%20L,%20Lemstra%20AW,%20ten%20Kate%20M,%20Padovani%20A,%20et%20al.%20A%20signature%20pattern%20of%20cortical%20atrophy%20in%20dementia%20with%20lewy%20bodies:%20A%20study%20on%20333%20patients%20from%20the%20European%20DLB%20consortium.%20Alzheimer%E2%80%99s%20Dement.%202019;15:400%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Ferreira D, Nordberg A, Westman E. Biological subtypes of alzheimer disease. Neurology. 2020;94:436–48.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000009058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7238917/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32047067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferreira%20D,%20Nordberg%20A,%20Westman%20E.%20Biological%20subtypes%20of%20alzheimer%20disease.%20Neurology.%202020;94:436%E2%80%9348." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F et al. β-Amyloid and Tau biomarkers and clinical phenotype in dementia with lewy bodies. Neurology. 2020;95.</cite> [<a href="https://doi.org/10.1212/WNL.0000000000010943" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7836666/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32989106/" class="usa-link">PubMed</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Abdelnour C, van Steenoven I, Londos E, Blanc F, Auestad B, Kramberger MG, et al. Alzheimer’s disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Mov Disord. 2016;31:1203–8.
</cite> [<a href="https://doi.org/10.1002/mds.26668" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27296778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abdelnour%20C,%20van%20Steenoven%20I,%20Londos%20E,%20Blanc%20F,%20Auestad%20B,%20Kramberger%20MG,%20et%20al.%20Alzheimer%E2%80%99s%20disease%20cerebrospinal%20fluid%20biomarkers%20predict%20cognitive%20decline%20in%20lewy%20body%20dementia.%20Mov%20Disord.%202016;31:1203%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Irwin DJ, Xie SX, Coughlin D, Nevler N, Akhtar RS, McMillan CT et al. CSF Tau and β-amyloid predict cerebral synucleinopathy in autopsied lewy body disorders. Neurology. 2018;90.</cite> [<a href="https://doi.org/10.1212/WNL.0000000000005166" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5874449/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29467305/" class="usa-link">PubMed</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Hansson O, Cullen N, Zetterberg H, Blennow K, Mattsson-Carlgren N. Plasma phosphorylated tau181 and neurodegeneration in alzheimer’s disease. Ann Clin Transl Neurol. 2021;8:259–65.
</cite> [<a href="https://doi.org/10.1002/acn3.51253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7818141/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33249783/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hansson%20O,%20Cullen%20N,%20Zetterberg%20H,%20Blennow%20K,%20Mattsson-Carlgren%20N.%20Plasma%20phosphorylated%20tau181%20and%20neurodegeneration%20in%20alzheimer%E2%80%99s%20disease.%20Ann%20Clin%20Transl%20Neurol.%202021;8:259%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Hsu J-L, Lee W-J, Liao Y-C, Lirng J-F, Wang S-J, Fuh J-L. Plasma biomarkers are associated with agitation and regional brain atrophy in alzheimer’s disease. Sci Rep. 2017;7:5035.
</cite> [<a href="https://doi.org/10.1038/s41598-017-05390-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5506051/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28698646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hsu%20J-L,%20Lee%20W-J,%20Liao%20Y-C,%20Lirng%20J-F,%20Wang%20S-J,%20Fuh%20J-L.%20Plasma%20biomarkers%20are%20associated%20with%20agitation%20and%20regional%20brain%20atrophy%20in%20alzheimer%E2%80%99s%20disease.%20Sci%20Rep.%202017;7:5035." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Tissot C, Benedet L, Therriault A, Pascoal J, Lussier TA, Saha-Chaudhuri FZ. Plasma pTau181 predicts cortical brain atrophy in aging and alzheimer’s disease. Alzheimers Res Ther. 2021;13:69.
</cite> [<a href="https://doi.org/10.1186/s13195-021-00802-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8008680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33781319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tissot%20C,%20Benedet%20L,%20Therriault%20A,%20Pascoal%20J,%20Lussier%20TA,%20Saha-Chaudhuri%20FZ.%20Plasma%20pTau181%20predicts%20cortical%20brain%20atrophy%20in%20aging%20and%20alzheimer%E2%80%99s%20disease.%20Alzheimers%20Res%20Ther.%202021;13:69." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Yang Z, Wang KKW. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364–74.
</cite> [<a href="https://doi.org/10.1016/j.tins.2015.04.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4559283/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25975510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20Z,%20Wang%20KKW.%20Glial%20fibrillary%20acidic%20protein:%20from%20intermediate%20filament%20assembly%20and%20gliosis%20to%20neurobiomarker.%20Trends%20Neurosci.%202015;38:364%E2%80%9374." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Coppens S, Lehmann S, Hopley C, Hirtz C. Neurofilament-Light, a promising biomarker: analytical, metrological and clinical challenges. Int J Mol Sci. 2023;24:11624.
</cite> [<a href="https://doi.org/10.3390/ijms241411624" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10380627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37511382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Coppens%20S,%20Lehmann%20S,%20Hopley%20C,%20Hirtz%20C.%20Neurofilament-Light,%20a%20promising%20biomarker:%20analytical,%20metrological%20and%20clinical%20challenges.%20Int%20J%20Mol%20Sci.%202023;24:11624." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Verberk IMW, Thijssen E, Koelewijn J, Mauroo K, Vanbrabant J, de Wilde A, et al. Combination of plasma amyloid beta(1–42/1–40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res Ther. 2020;12:118.
</cite> [<a href="https://doi.org/10.1186/s13195-020-00682-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7523295/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32988409/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Verberk%20IMW,%20Thijssen%20E,%20Koelewijn%20J,%20Mauroo%20K,%20Vanbrabant%20J,%20de%20Wilde%20A,%20et%20al.%20Combination%20of%20plasma%20amyloid%20beta(1%E2%80%9342/1%E2%80%9340)%20and%20glial%20fibrillary%20acidic%20protein%20strongly%20associates%20with%20cerebral%20amyloid%20pathology.%20Alzheimers%20Res%20Ther.%202020;12:118." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>van Gennip ACE, Satizabal CL, Tracy RP, Sigurdsson S, Gudnason V, Launer LJ, et al. Associations of plasma nfl, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik study. Geroscience. 2023;46:505–16.
</cite> [<a href="https://doi.org/10.1007/s11357-023-00888-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10828267/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37530894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Gennip%20ACE,%20Satizabal%20CL,%20Tracy%20RP,%20Sigurdsson%20S,%20Gudnason%20V,%20Launer%20LJ,%20et%20al.%20Associations%20of%20plasma%20nfl,%20GFAP,%20and%20t-tau%20with%20cerebral%20small%20vessel%20disease%20and%20incident%20dementia:%20longitudinal%20data%20of%20the%20AGES-Reykjavik%20study.%20Geroscience.%202023;46:505%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Donaghy PC, Firbank M, Petrides G, Lloyd J, Barnett N, Olsen K, et al. The relationship between plasma biomarkers and amyloid PET in dementia with lewy bodies. Parkinsonism Relat Disord. 2022;101:111–6.
</cite> [<a href="https://doi.org/10.1016/j.parkreldis.2022.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35872565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Donaghy%20PC,%20Firbank%20M,%20Petrides%20G,%20Lloyd%20J,%20Barnett%20N,%20Olsen%20K,%20et%20al.%20The%20relationship%20between%20plasma%20biomarkers%20and%20amyloid%20PET%20in%20dementia%20with%20lewy%20bodies.%20Parkinsonism%20Relat%20Disord.%202022;101:111%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Bolsewig K, van Unnik AAJM, Blujdea ER, Gonzalez MC, Ashton NJ, Aarsland D et al. Association of plasma amyloid, P-Tau, GFAP, and NfL with CSF, clinical, and cognitive features in patients with dementia with lewy bodies. Neurology. 2024;102.</cite> [<a href="https://doi.org/10.1212/WNL.0000000000209418" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11244745/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38830138/" class="usa-link">PubMed</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Gonzalez MC, Ashton NJ, Gomes BF, Tovar-Rios DA, Blanc F, Karikari TK, et al. Association of plasma p-tau181 and p-tau231 concentrations with cognitive decline in patients with probable dementia with lewy bodies. JAMA Neurol. 2022;79:32.
</cite> [<a href="https://doi.org/10.1001/jamaneurol.2021.4222" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8609462/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34807233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gonzalez%20MC,%20Ashton%20NJ,%20Gomes%20BF,%20Tovar-Rios%20DA,%20Blanc%20F,%20Karikari%20TK,%20et%20al.%20Association%20of%20plasma%20p-tau181%20and%20p-tau231%20concentrations%20with%20cognitive%20decline%20in%20patients%20with%20probable%20dementia%20with%20lewy%20bodies.%20JAMA%20Neurol.%202022;79:32." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial Temporal lobes on MRI in probable alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55:967–72.
</cite> [<a href="https://doi.org/10.1136/jnnp.55.10.967" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1015202/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1431963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Scheltens%20P,%20Leys%20D,%20Barkhof%20F,%20Huglo%20D,%20Weinstein%20HC,%20Vermersch%20P,%20et%20al.%20Atrophy%20of%20medial%20Temporal%20lobes%20on%20MRI%20in%20probable%20alzheimer%E2%80%99s%20disease%20and%20normal%20ageing:%20diagnostic%20value%20and%20neuropsychological%20correlates.%20J%20Neurol%20Neurosurg%20Psychiatry.%201992;55:967%E2%80%9372." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, et al. Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition. Eur Radiol. 2016;26:2597–610.
</cite> [<a href="https://doi.org/10.1007/s00330-015-4101-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26560730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferreira%20D,%20Cavallin%20L,%20Granberg%20T,%20Lindberg%20O,%20Aguilar%20C,%20Mecocci%20P,%20et%20al.%20Quantitative%20validation%20of%20a%20visual%20rating%20scale%20for%20frontal%20atrophy:%20associations%20with%20clinical%20status,%20APOE%20e4,%20CSF%20biomarkers%20and%20cognition.%20Eur%20Radiol.%202016;26:2597%E2%80%93610." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Koedam ELGE, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YAL, Fox N, et al. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol. 2011;21:2618–25.
</cite> [<a href="https://doi.org/10.1007/s00330-011-2205-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3217148/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21805370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koedam%20ELGE,%20Lehmann%20M,%20van%20der%20Flier%20WM,%20Scheltens%20P,%20Pijnenburg%20YAL,%20Fox%20N,%20et%20al.%20Visual%20assessment%20of%20posterior%20atrophy%20development%20of%20a%20MRI%20rating%20scale.%20Eur%20Radiol.%202011;21:2618%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R. MR signal abnormalities at 1.5 T in alzheimer’s dementia and normal aging. Am J Roentgenol. 1987;149:351–6.
</cite> [<a href="https://doi.org/10.2214/ajr.149.2.351" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3496763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fazekas%20F,%20Chawluk%20J,%20Alavi%20A,%20Hurtig%20H,%20Zimmerman%20R.%20MR%20signal%20abnormalities%20at%201.5%20T%20in%20alzheimer%E2%80%99s%20dementia%20and%20normal%20aging.%20Am%20J%20Roentgenol.%201987;149:351%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Oppedal K, Borda MG, Ferreira D, Westman E, Aarsland D. European Dlb consortium: diagnostic and prognostic biomarkers in dementia with lewy bodies, a multicenter international initiative. Neurodegener Dis Manag. 2019;9:247–50.
</cite> [<a href="https://doi.org/10.2217/nmt-2019-0016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31580225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oppedal%20K,%20Borda%20MG,%20Ferreira%20D,%20Westman%20E,%20Aarsland%20D.%20European%20Dlb%20consortium:%20diagnostic%20and%20prognostic%20biomarkers%20in%20dementia%20with%20lewy%20bodies,%20a%20multicenter%20international%20initiative.%20Neurodegener%20Dis%20Manag.%202019;9:247%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psychiatr Res. 1975;12:189–98.
</cite> [<a href="https://doi.org/10.1016/0022-3956(75)90026-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1202204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Folstein%20MF,%20Folstein%20SE,%20McHugh%20PR.%20Mini-mental%20state.%20J%20Psychiatr%20Res.%201975;12:189%E2%80%9398." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Ferreira D, Verhagen C, Hernández-Cabrera JA, Cavallin L, Guo C-J, Ekman U, et al. Distinct subtypes of alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications. Sci Rep. 2017;7:46263.
</cite> [<a href="https://doi.org/10.1038/srep46263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5394684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28417965/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferreira%20D,%20Verhagen%20C,%20Hern%C3%A1ndez-Cabrera%20JA,%20Cavallin%20L,%20Guo%20C-J,%20Ekman%20U,%20et%20al.%20Distinct%20subtypes%20of%20alzheimer%E2%80%99s%20disease%20based%20on%20patterns%20of%20brain%20atrophy:%20longitudinal%20trajectories%20and%20clinical%20applications.%20Sci%20Rep.%202017;7:46263." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Ferreira D, Cavallin L, Larsson E-M, Muehlboeck J, ‐S., Mecocci P, Vellas B, et al. Practical cut‐offs for visual rating scales of medial temporal, frontal and posterior atrophy in &lt; scp &gt; a lzheimer’s disease and mild cognitive impairment. J Intern Med. 2015;278:277–90.
</cite> [<a href="https://doi.org/10.1111/joim.12358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25752192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferreira%20D,%20Cavallin%20L,%20Larsson%20E-M,%20Muehlboeck%20J,%20%E2%80%90S.,%20Mecocci%20P,%20Vellas%20B,%20et%20al.%20Practical%20cut%E2%80%90offs%20for%20visual%20rating%20scales%20of%20medial%20temporal,%20frontal%20and%20posterior%20atrophy%20in%20&lt;%E2%80%89scp%E2%80%89&gt;%E2%80%89a%E2%80%89lzheimer%E2%80%99s%20disease%20and%20mild%20cognitive%20impairment.%20J%20Intern%20Med.%202015;278:277%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Oltra J, Habich A, Schwarz CG, Nedelska Z, Przybelski SA, Inguanzo A, et al. Sex differences in brain atrophy in dementia with lewy bodies. Alzheimer’s Dement. 2024;20:1815–26.
</cite> [<a href="https://doi.org/10.1002/alz.13571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10947875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38131463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oltra%20J,%20Habich%20A,%20Schwarz%20CG,%20Nedelska%20Z,%20Przybelski%20SA,%20Inguanzo%20A,%20et%20al.%20Sex%20differences%20in%20brain%20atrophy%20in%20dementia%20with%20lewy%20bodies.%20Alzheimer%E2%80%99s%20Dement.%202024;20:1815%E2%80%9326." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Joki H, Higashiyama Y, Nakae Y, Kugimoto C, Doi H, Kimura K, et al. White matter hyperintensities on MRI in dementia with lewy bodies, parkinson’s disease with dementia, and alzheimer’s disease. J Neurol Sci. 2018;385:99–104.
</cite> [<a href="https://doi.org/10.1016/j.jns.2017.12.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29406924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Joki%20H,%20Higashiyama%20Y,%20Nakae%20Y,%20Kugimoto%20C,%20Doi%20H,%20Kimura%20K,%20et%20al.%20White%20matter%20hyperintensities%20on%20MRI%20in%20dementia%20with%20lewy%20bodies,%20parkinson%E2%80%99s%20disease%20with%20dementia,%20and%20alzheimer%E2%80%99s%20disease.%20J%20Neurol%20Sci.%202018;385:99%E2%80%93104." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Maciej T, Ewa T. The need to report effect size estimates revisited.an overview of some recommended measures of effect size. Trends Sport Sci. 2014;1:19–25.</cite> [<a href="https://scholar.google.com/scholar_lookup?Maciej%20T,%20Ewa%20T.%20The%20need%20to%20report%20effect%20size%20estimates%20revisited.an%20overview%20of%20some%20recommended%20measures%20of%20effect%20size.%20Trends%20Sport%20Sci.%202014;1:19%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Chong JR, Hilal S, Ashton NJ, Karikari TK, Reilhac A, Vrooman H, et al. Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease. Volume 15. Alzheimer’s &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring; 2023.</cite> [<a href="https://doi.org/10.1002/dad2.12396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10040495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36994314/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chong%20JR,%20Hilal%20S,%20Ashton%20NJ,%20Karikari%20TK,%20Reilhac%20A,%20Vrooman%20H,%20et%20al.%20Brain%20atrophy%20and%20white%20matter%20hyperintensities%20are%20independently%20associated%20with%20plasma%20neurofilament%20light%20chain%20in%20an%20Asian%20cohort%20of%20cognitively%20impaired%20patients%20with%20concomitant%20cerebral%20small%20vessel%20disease.%20Volume%2015.%20Alzheimer%E2%80%99s%20&amp;%20Dementia:%20Diagnosis,%20Assessment%20&amp;%20Disease%20Monitoring;%202023." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Arslan B, Zetterberg H. Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice? Clin Chem Lab Med (CCLM). 2023;61:1140–9.
</cite> [<a href="https://doi.org/10.1515/cclm-2023-0036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36880940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arslan%20B,%20Zetterberg%20H.%20Neurofilament%20light%20chain%20as%20neuronal%20injury%20marker%20%E2%80%93%20what%20is%20needed%20to%20facilitate%20implementation%20in%20clinical%20laboratory%20practice?%20Clin%20Chem%20Lab%20Med%20(CCLM).%202023;61:1140%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Shahim P, Pham DL, van der Merwe AJ, Moore B, Chou Y, Lippa SM, et al. Serum NfL and GFAP as biomarkers of progressive neurodegeneration in TBI. Alzheimer’s Dement. 2024;20:4663–76.
</cite> [<a href="https://doi.org/10.1002/alz.13898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11247683/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38805359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shahim%20P,%20Pham%20DL,%20van%20der%20Merwe%20AJ,%20Moore%20B,%20Chou%20Y,%20Lippa%20SM,%20et%20al.%20Serum%20NfL%20and%20GFAP%20as%20biomarkers%20of%20progressive%20neurodegeneration%20in%20TBI.%20Alzheimer%E2%80%99s%20Dement.%202024;20:4663%E2%80%9376." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Ammitzbøll C, Dyrby TB, Börnsen L, Schreiber K, Ratzer R, Romme Christensen J, et al. NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis. Mult Scler Relat Disord. 2023;77:104854.
</cite> [<a href="https://doi.org/10.1016/j.msard.2023.104854" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37418931/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ammitzb%C3%B8ll%20C,%20Dyrby%20TB,%20B%C3%B6rnsen%20L,%20Schreiber%20K,%20Ratzer%20R,%20Romme%20Christensen%20J,%20et%20al.%20NfL%20and%20GFAP%20in%20serum%20are%20associated%20with%20microstructural%20brain%20damage%20in%20progressive%20multiple%20sclerosis.%20Mult%20Scler%20Relat%20Disord.%202023;77:104854." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Gallingani C, Carbone C, Tondelli M, Zamboni G. Neurofilaments light chain in neurodegenerative dementias: A review of imaging correlates. Brain Sci. 2024;14:272.
</cite> [<a href="https://doi.org/10.3390/brainsci14030272" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10968996/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38539660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gallingani%20C,%20Carbone%20C,%20Tondelli%20M,%20Zamboni%20G.%20Neurofilaments%20light%20chain%20in%20neurodegenerative%20dementias:%20A%20review%20of%20imaging%20correlates.%20Brain%20Sci.%202024;14:272." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Kong Q, Xie X, Wang Z, Zhang Y, Zhou X, Wu L, et al. Correlations of plasma biomarkers and imaging characteristics of cerebral small vessel disease. Brain Sci. 2024;14:269.
</cite> [<a href="https://doi.org/10.3390/brainsci14030269" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10969111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38539657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kong%20Q,%20Xie%20X,%20Wang%20Z,%20Zhang%20Y,%20Zhou%20X,%20Wu%20L,%20et%20al.%20Correlations%20of%20plasma%20biomarkers%20and%20imaging%20characteristics%20of%20cerebral%20small%20vessel%20disease.%20Brain%20Sci.%202024;14:269." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Edwards NC, Lao PJ, Alshikho MJ, Ericsson OM, Rizvi B, Petersen ME et al. Cerebrovascular disease drives alzheimer plasma biomarker concentrations in adults with down syndrome. Preprint medRxiv. 2023.</cite> [<a href="https://doi.org/10.1093/braincomms/fcae331" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11472828/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39403075/" class="usa-link">PubMed</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Nedelska Z, Schwarz CG, Boeve BF, Lowe VJ, Reid RI, Przybelski SA, et al. White matter integrity in dementia with lewy bodies: a voxel-based analysis of diffusion tensor imaging. Neurobiol Aging. 2015;36:2010–7.
</cite> [<a href="https://doi.org/10.1016/j.neurobiolaging.2015.03.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4433563/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25863527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nedelska%20Z,%20Schwarz%20CG,%20Boeve%20BF,%20Lowe%20VJ,%20Reid%20RI,%20Przybelski%20SA,%20et%20al.%20White%20matter%20integrity%20in%20dementia%20with%20lewy%20bodies:%20a%20voxel-based%20analysis%20of%20diffusion%20tensor%20imaging.%20Neurobiol%20Aging.%202015;36:2010%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Abdelnour C, Ferreira D, Oppedal K, Cavallin L, Bousiges O, Wahlund LO, et al. The combined effect of amyloid-β and Tau biomarkers on brain atrophy in dementia with lewy bodies. Neuroimage Clin. 2020;27:102333.
</cite> [<a href="https://doi.org/10.1016/j.nicl.2020.102333" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7363702/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32674011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abdelnour%20C,%20Ferreira%20D,%20Oppedal%20K,%20Cavallin%20L,%20Bousiges%20O,%20Wahlund%20LO,%20et%20al.%20The%20combined%20effect%20of%20amyloid-%CE%B2%20and%20Tau%20biomarkers%20on%20brain%20atrophy%20in%20dementia%20with%20lewy%20bodies.%20Neuroimage%20Clin.%202020;27:102333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Pichet Binette A, Mammana A, Wisse L, Rossi M, Strandberg O, Smith R, et al. Associations between misfolded alpha-synuclein aggregates and alzheimer’s disease pathology in vivo. Alzheimer’s Dement. 2024;20:7624–34.
</cite> [<a href="https://doi.org/10.1002/alz.14225" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11567871/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39258841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pichet%20Binette%20A,%20Mammana%20A,%20Wisse%20L,%20Rossi%20M,%20Strandberg%20O,%20Smith%20R,%20et%20al.%20Associations%20between%20misfolded%20alpha-synuclein%20aggregates%20and%20alzheimer%E2%80%99s%20disease%20pathology%20in%20vivo.%20Alzheimer%E2%80%99s%20Dement.%202024;20:7624%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Wan M, Liu H, Liu X, Zhang W, Xiao X, Zhang S et al. Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with alzheimer’s disease. Front Aging Neurosci. 2022;14.</cite> [<a href="https://doi.org/10.3389/fnagi.2022.906519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9374170/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35966797/" class="usa-link">PubMed</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Bos I, Verhey FR, Ramakers IHGB, Jacobs HIL, Soininen H, Freund-Levi Y, et al. Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline. Alzheimers Res Ther. 2017;9:101.
</cite> [<a href="https://doi.org/10.1186/s13195-017-0328-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5747152/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29284531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bos%20I,%20Verhey%20FR,%20Ramakers%20IHGB,%20Jacobs%20HIL,%20Soininen%20H,%20Freund-Levi%20Y,%20et%20al.%20Cerebrovascular%20and%20amyloid%20pathology%20in%20predementia%20stages:%20the%20relationship%20with%20neurodegeneration%20and%20cognitive%20decline.%20Alzheimers%20Res%20Ther.%202017;9:101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Hol EM, Roelofs RF, Moraal E, Sonnemans MAF, Sluijs JA, Proper EA, et al. Neuronal expression of GFAP in patients with alzheimer pathology and identification of novel GFAP splice forms. Mol Psychiatry. 2003;8:786–96.
</cite> [<a href="https://doi.org/10.1038/sj.mp.4001379" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12931206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hol%20EM,%20Roelofs%20RF,%20Moraal%20E,%20Sonnemans%20MAF,%20Sluijs%20JA,%20Proper%20EA,%20et%20al.%20Neuronal%20expression%20of%20GFAP%20in%20patients%20with%20alzheimer%20pathology%20and%20identification%20of%20novel%20GFAP%20splice%20forms.%20Mol%20Psychiatry.%202003;8:786%E2%80%9396." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Baiardi S, Quadalti C, Mammana A, Dellavalle S, Zenesini C, Sambati L, et al. Diagnostic value of plasma p-tau181, nfl, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias. Alzheimers Res Ther. 2022;14:153.
</cite> [<a href="https://doi.org/10.1186/s13195-022-01093-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9555092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36221099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baiardi%20S,%20Quadalti%20C,%20Mammana%20A,%20Dellavalle%20S,%20Zenesini%20C,%20Sambati%20L,%20et%20al.%20Diagnostic%20value%20of%20plasma%20p-tau181,%20nfl,%20and%20GFAP%20in%20a%20clinical%20setting%20cohort%20of%20prevalent%20neurodegenerative%20dementias.%20Alzheimers%20Res%20Ther.%202022;14:153." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Thijssen EH, Verberk IMW, Kindermans J, Abramian A, Vanbrabant J, Ball AJ, et al. Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia. Volume 14. Alzheimer’s &amp; Dementia: Diagnosis, Assessment &amp; Disease Monitoring.; 2022.</cite> [<a href="https://doi.org/10.1002/dad2.12285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9107685/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35603139/" class="usa-link">PubMed</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Thomas AJ, Hamilton CA, Heslegrave A, Barker S, Durcan R, Lawley S, et al. A longitudinal study of Plasma &lt; scp &gt; pTau181 in mild cognitive impairment with lewy bodies and alzheimer’s disease. Mov Disord. 2022;37:1495–504.
</cite> [<a href="https://doi.org/10.1002/mds.28994" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9540809/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35318733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Thomas%20AJ,%20Hamilton%20CA,%20Heslegrave%20A,%20Barker%20S,%20Durcan%20R,%20Lawley%20S,%20et%20al.%20A%20longitudinal%20study%20of%20Plasma%E2%80%89&lt;%E2%80%89scp%E2%80%89&gt;%E2%80%89pTau181%E2%80%89in%20mild%20cognitive%20impairment%20with%20lewy%20bodies%20and%20alzheimer%E2%80%99s%20disease.%20Mov%20Disord.%202022;37:1495%E2%80%93504." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>O’Donovan J, Watson R, Colloby SJ, Firbank MJ, Burton EJ, Barber R, et al. Does posterior cortical atrophy on MRI discriminate between alzheimer’s disease, dementia with lewy bodies, and normal aging? Int Psychogeriatr. 2013;25:111–9.
</cite> [<a href="https://doi.org/10.1017/S1041610212001214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22809815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?O%E2%80%99Donovan%20J,%20Watson%20R,%20Colloby%20SJ,%20Firbank%20MJ,%20Burton%20EJ,%20Barber%20R,%20et%20al.%20Does%20posterior%20cortical%20atrophy%20on%20MRI%20discriminate%20between%20alzheimer%E2%80%99s%20disease,%20dementia%20with%20lewy%20bodies,%20and%20normal%20aging?%20Int%20Psychogeriatr.%202013;25:111%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Zhu H, Lu H, Wang F, Liu S, Shi Z, Gan J et al. Characteristics of cortical atrophy and white matter lesions between dementia with lewy bodies and alzheimer’s disease: A Case-Control study. Front Neurol. 2022;12.</cite> [<a href="https://doi.org/10.3389/fneur.2021.779344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8788384/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35087466/" class="usa-link">PubMed</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, et al. Accuracy of clinical diagnosis of dementia with lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2018;89:358–66.
</cite> [<a href="https://doi.org/10.1136/jnnp-2017-316844" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29030419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rizzo%20G,%20Arcuti%20S,%20Copetti%20M,%20Alessandria%20M,%20Savica%20R,%20Fontana%20A,%20et%20al.%20Accuracy%20of%20clinical%20diagnosis%20of%20dementia%20with%20lewy%20bodies:%20a%20systematic%20review%20and%20meta-analysis.%20J%20Neurol%20Neurosurg%20Psychiatry.%202018;89:358%E2%80%9366." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Ferman TJ, Boeve BF, Smith GE, Lin S-C, Silber MH, Pedraza O, et al. Inclusion of RBD improves the diagnostic classification of dementia with lewy bodies. Neurology. 2011;77:875–82.
</cite> [<a href="https://doi.org/10.1212/WNL.0b013e31822c9148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3162640/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21849645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferman%20TJ,%20Boeve%20BF,%20Smith%20GE,%20Lin%20S-C,%20Silber%20MH,%20Pedraza%20O,%20et%20al.%20Inclusion%20of%20RBD%20improves%20the%20diagnostic%20classification%20of%20dementia%20with%20lewy%20bodies.%20Neurology.%202011;77:875%E2%80%9382." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374387/bin/13195_2025_1848_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (34KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Alzheimer's Research &amp; Therapy are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s13195-025-01848-x"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/13195_2025_Article_1848.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374387/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374387/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374387%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374387/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374387/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374387/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40847319/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374387/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40847319/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374387/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374387/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="2ZrgnIit2Eep6rnKrPgB04xcipiy0Ko5kprKYGqenL4orErYPlcEnx4K9jeYGEAm">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
